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NEARLYN a quarter of a century has elapsed since the first animal tumours
were produced by the application of pure polycyclic aromatic hydrocarbons,
and there is still complete ignorance as to the mechanism of local carcinogenic
action. It is not known whether it is due to the intact hydrocarbon or to a
metabolite, and which of the cell constituents are involved in the process.
Metabolic studies undertaken with a view to obtaining information as to the
mechanism of the carcinogenic process have not yet solved the problem. They
revealed, however, that the hydrocarbon undergoes metabolic changes, including
oxidation to phenolic derivatives, quinones and acids formed by ring-degradation.
Only a small fraction is eliminated in the form of unchanged hydrocarbon. The
first step in the metabolic chain of events may be the binding ofthe hydrocarbon
by a cell constituent (probably a protein) as suggested by the experiments of
Weigert and Mottram (1946a, 1946b) and Miller (1950, 1951), followed by a local
change to an acidic derivative, the nature of which is not yet known, as no pure
products have so far been isolated from the metabolites occurring locally. Further
changes seem to take place in the liver and during the passage through the
intestines (Peacock, 1936; Chalmers and Peacock, 1936, 1941; Weigert and
Mottram, 1946a, 1946b).
The metabolites of carcinogenic hydrocarbons, so far identified, have been
isolated from the excreta of animals, but they are present in the circulating blood
and may affect the carcinogenic process. It is, therefore, of importance to test
the carcinogenic activity of each metabolite which becomes available in the pure
state.
Only three phenolic metabolites of carcinogenic hydrocarbons have so far
been tested for carcinogenic activity. The two dihydroxy-derivatives of 1:2:5:6-
dibenzanthracene proved inactive (Boyland, Levi, Mawson and Roe, 1941;
Dobriner, Rhoads and Lavin, 1942; Dunlap and Warren, 1941), while the crude
fraction of phenolic metabolites of 3:4-benzpyrene gave one sarcoma in 10 mice
tested by the subcutaneous route and one mammary tumour, the spontaneous
origin of which could not be excluded (Berenblum and Schoental, 1943).
Since then, 8- and 10-hydroxy-derivatives have been identified as phenolic
metabolites of 3:4-benzpyrene in mice, rats, and rabbits (Berenblum and Schoen-
tal, 1946), and their structures established by direct comparison oftheir respective
methylation products with the synthetic 8- and 10-methoxy-3:4-benzpyrenes
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(Cook, Ludwiczak and Schoental, 1950). The method of synthesis of 8-hydroxy-
3:4-benzpyrene and its methyl ether enabled these pure compounds to be pre-
pared in quantities adequate for biological testing. The results ofthese tests are
now reported, as well as those with 8-methyl-3:4-benzpyrene, which has been
synthesised for comparison with the 8-methoxy-compound (Cameron, Cook and
Schoental, 1952).
MATERIAL AND METHODS.
Mice were used for the testing of carcinogenic activity of the pure synthetic
8-hydroxy-, 8-methoxy- and 8-methyl-3:4-benzpyrene. 8-Methoxy-benzpyrene
was tested also in rats.
The mice were derived from one pair of CBA strain and were bred locally, as
were also the rats which were derived from a commercial stock of albino Wistar
rats. The animals were housed in metal cages and received rat cake and tap
water ad libitum.
Freshly prepared solutions (the solvents used were redistilled and freed from
fluorescent impurities) of the pure crystalline substances (0.5 per cent solution
in acetone in the case of 8-hydroxy-3-4-benzpyrene, a saturated solution in
acetone or a 0*5 per cent solution in benzene in the case of 8-methoxy-3:4-benz-
pyrene) were applied twice a week to the intrascapular region of the skin from a
capillary pipette, the hair being removed by clipping with scissors. For sub-
cutaneous injections the pure compounds were dissolved in tricaprylin, and the
animals were injected in the left flank, care being taken to prevent leakage ofthe
oily solutions. In the majority of cases the injected oily solution formed a
defined nodule palpable under the skin and remaining in situ for many weeks or
months. The animals were allowed to live as long as possible; but some were
killed when moribund, or when the induced tumours attained excessive size.
All the animals were examined post mortem, and the tumours and other observed
abnormalities confirmed by histological examination. To obtain evidence of
the degree of malignancy some of the tumours have been transplanted for several
generations into the respective species of animal, and their histological appearance
confirmed in the transplants.
RESULTS.
Table I summarizes the results of testing of 8-hydroxy-3:4-benzpyrene. This
compound did not produce any local tumours in the 16 mice (10 males and 6
females), into each of which it was injected subcutaneously in two doses, 2 mg.
each at 5 months' interval, although 14 animals were alive after 52 weeks, 12
after 79 weeks, and the last 2 were killed when the experiment was terminated
117 weeks after the first injection. Several of the mice exhibited different
degrees of leucoses which might have been spontaneous (in the control group of
these CBA mice leucoses were also encountered), or accentuated by the action
of this compound.
In the animals receiving skin applications of a 0.5 per cent solution of 8-
hydroxy-3:4-benzpyrene in acetone (special care was taken to minimise the
decomposition of this labile compound by dissolving only very small quantities
at a time andkeeping the solution in a darkbottle) the treatedskin areas remained
smooth and soft, and no abnormalities were visible during the first 69 weeks of
treatment. However, on continued application small papillomata appeared,
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which grew progessively; five of these became malignant. The experiment was
terminated 121 weeks after the beginning of treatment; about 50 per cent of the
animals had some neoplastic local changes.
Table II gives the results of testing 8-methoxy-3:4-benzpyrene in mice and
rats. This compoundproved to be one ofthe strongest carcinogens so far known,
probably exceeding in potency the parent 3:4-benzpyrene. Thus application of
its saturated acetone solution (less than0.2 per cent) to the skin of mice produced
local depilation, dark pigmentation and desquamation a few days after the
treatment began; papillomata arose in multiple foci10 weeks after the beginning
oftreatment, so that 50 per cent ofthe animals had tumours after 14 weeks, and
100 per cent after 22 weeks. Ten mice were killed after 27 weeks of treatment
and 9 of these had multiple malignant tumours invading the underlying skeletal
muscle; one had only multiple papillomata. The experiment was terminated
after 41 weeks, when the 4 remainingmice with carcinoma were killed. The
papillomata from the multiple foci gave in many cases big confluent malignant
tumours occupying an area ofup to 3 x 1-5 cm. at the site ofapplication.
On subcutaneous injection of 2 mg. in 0.2 ml. of tricaprylin, 8-methoxy-
3:4-benzpyrene proved very irritating and ulceration and discharge of the
substance occurred in about 4 weeks after the injection; this effect was more
pronounced in the female series. Consequently tumours appeared later among
the females (the first tumour appeared after 22weeks, and 50 per cent of the
animals had tumours after 26 weeks) than among the male mice (in which the
first tumourappeared after11 weeks and 50per cent after 22 weeks). In another
experiment 16 mice wereinjected each with0.5 mg. of 8-methoxy-3:4-benzpyrene
in 0.1 ml. oftricaprylin, but in spite of this reduced dosage some ulcerationstill
occurred. In this series the first tumour appeared 10 weeks after the injection
and 50per cent ofthe animals had tumours in 14 weeks. However, in both series
the extrusion of the material might have been responsible for the non-appearance
of tumours in several animals. Still lower dosage would be necessary to obtain
truly representative data as to thecarcinogenic response of mice. In one case
a tumour at the site ofa scarappeared as late as 83 weeks after the injection.
No irritation was observed in the rats tested by the subcutaneous route.
All the 11 animals developed sarcomata; the first appeared in 16 weeks and
50 per cent of the rats had tumours 19 weeks after the first injection.
8-Methoxy-3:4-benzpyrene was tested also by skin application in rats. A
saturated acetone solution applied twice weekly to the intrascapular region for
39 weeks did not seem to produce macroscopic changes. Subsequently a 0.5
per cent solution of this compound in benzene was applied. The treated area
became depilated, scaly, and papillomata started to appear. It is not unlikely
that the longinduction period ofthese tumours (about 1year) might have been
shortened if the more concentrated benzene solution had been applied from the
beginning of treatment. Once the papillomata appeared they readily became
malignant, andkeratinoushorn-like structuresgrewto enormous size (5 x 5 x4.5
cm.) between the ears of the rats. Several of these tumours metastasised to the
local nymph nodes. The rat shown in Fig. 1is a representative example. It
shows besides the primary tumour a metastasis which formed a keratinised mass
(1-5 x 1.5cm.) in the submaxillary gland. Two of these tumours were trans-
planted into weanling rats, and carried successfully through three generations
oftransplants, which retained theability to form keratin.
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FxI(. 1. Horn-like tumour ill a rat at the site of application of 8-methoxy-3:4-benzpyrellne
and metastasis in the submaxillary glanid, 17 months after the first, anid 3 moniths after
the last application.
(C'ook and Schoeital.
BRITISI-I JOURNAL 01' CANCEIt.CARCINOGENIC PRODUCTS OF BENZPYRENE
._4
$4 =
.Oe R
4.03 Q
O 0
O
-9
*~~~~~~~a 4 O
~ °
ii
· o · or+O
*4 * . .
Q
(D
0 1
o
CO
10
o
<n
I
410
.
P4 w ,d4 0
_.r4 Q
m
o0
0
(D 0
o~ rco -
CO
· o)
I-
CO oo
* . .
·so·
>1-
0 0
0
CO
* . I
3
·o ·
*+ . .
pa
R1
0 c
-
o
10
*~~~~~~
.
U; P A et P4 P4
P- 10 = 010co
m Q
0.) . .
403
m
00
0
· o ·
004 C)
-
CO
0
01
0)
0M
OQ
D-
4d
¢))
o
o0
0~
4-al
04
C) 7
0 4
0
- t-
0D
1
0 C)
I
'~0
* *Ca
0 0
CO
escq
ob
004
*
CO
0.)
.)
0 c
m
-
I
0
0 0
0 ~0
O
..a
ry'
0C
., *~
114
.
34 0D
0D
01-4 4~
>,
cd OD
1 ) 1. ) 1
q ~ 115
0
m
R)
IC 0
_s *0 c O=
28
Ro 8
o
4Z
0 0
m-0
CS2 ll
145J. W. COOK AND R. SCHOENTAL
Table III gives the results of subcutaneous testing of 8-methyl-3:4-benzpyrene
in mice. At the dosage of 1 mg. in 0.1 ml. tricaprylin this compound produced
TABLE III.-Incidence of Tumours in Mice Injected Subcutaneously with
8-Methyl-3:4-benzpyrene.
Time of appearance
Number Dose. of tumours. Duration of Number
and sex. A , _ -- experiment. of tumours.
First. 50%.
11 M. . 1 mg./0. 1 ml. . 13 weeks . 14 weeks . 27 weeks . 11 sarcomas.
7 F. . ditto . 13 ,, . 15 ,, . 27 ,, . 7 ,,
some local irritation; the first tumour appeared after 13 weeks, and 50 per cent
of the mice had tumours by about 14 weeks after the injections. All the 18
injected mice developed highly malignant tumours invading the adjacent muscle
and other tissues. One of these tumours was carried through 3 generations of
transplants, retaining its original structure.
DISCUSSION.
The results here reported present several points of interest.
(a) It is the first time that carcinogenic activity has been demonstrated by
the application to the skin of a phenolic metabolite of a carcinogenic hydrocarbon
(pure 8-hydroxy-3:4-benzpyrene) in mice. However, the very long induction
period (69 weeks for the appearance of the first papilloma and 113 weeks for
tumours to develop in 50 per cent of the animals) corresponds with or rather
exceeds the survival times of mice in the carcinogenic tests with the other known
metabolites. Hence a low degree of carcinogenic activity such as is exhibited by
8-hydroxy-3:4-benzpyrene may not be as isolated a phenomenon as it seems at
present.
No tumours were produced by subcutaneous injection ofthis compound, which
in conjunction with the above results makes it obvious that the carcinogenicity
of the parent hydrocarbon is considerably reduced (although not completely
abolished) by its metabolic transformation into a phenolic derivative. Of the
other benzpyrenols so far tested the 4'- (Cook and de Worms, 1937; Shear,
1939), 2- (Dunlap and Warren, 1941) and 5- (Shear and Leiter, 1940) compounds
were inactive, while the 6-isomer produced tumours in 2 out of 40 mice when
injected subcutaneously (Dunlap and Warren, 1941).
(b) Of particular interest is the finding that 8-methoxy-3:4-benzpyrene
exhibits a sarcomatogenic and carcinogenic activity of the highest order in both
the species tested, mice and rats. While rats are known to develop sarcomata
readily on subcutaneous injections of carcinogens, not many skin tumours have
been produced in rats by the application oftar or pure carcinogenic hydrocarbons.
Berenblum (1949) summarized the relevant literature when he reported on the
carcinogenicity of 9:10-dimethyl-1:2-benzanthracene. The latter proved very
effective for rat skin, giving rise to 14 tumours (11 of these were malignant) in
20 rats when applied once a week as a 0.5 per cent solution in benzene during
45 weeks.
By comparison with 9:10-dimethyl-1:2-benzanthracene (potency Grade VI,
when graded according to the system of Berenblum (1945)), 8-methoxy-3:4-
benzpyrene showed towards the skin of rats the potency Grade V, only a little
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weaker than the former. However, both compounds were equally effective in
their sarcomatogenic action (Grade VII).
8-Methoxy-3:4-benzpyrene proved rather irritating when injected sub-
cutaneously into mice, resembling in this repect 9:10-dimethyl-1:2-benzanthra-
cene and related compounds (Bachmann, Kennaway and Kennaway, 1938).
Thetissues sloughed off4 to 5 weeks after the injection, and mostofthecompound
was discharged. Thus in mice the results of subcutaneous injection are probably
not truly representative, and more reliable data could be obtained with a lower
dosage. In the two experiments with this compound using 2 mg./0.2 ml. and
0.5 mg./0.1 ml. per mouse respectively, tumours appeared earlier following the
lower dosage, but even the latter was too irritating and many animals remained
with scars, tumour-free, for many months.
The outstanding carcinogenic activity of 8-methoxy-3:4-benzpyrene is not
shared by the other two isomers so far tested, namely, 4'- and 5-methoxy-3:4-
benzpyrenes (Cook and de Worms, 1937; Shear, 1939; Berenblum and Schoental,
1944), nor by 4'-methoxy-9:10-dimethyl-1:2:benzanthracene, considered to be
the methylation product of the phenolic rat metabolite ofthe highly carcinogenic
9:10-dimethyl-1:2-benzanthracene (Dickens, 1946). With the exception of 5-
methoxy-3:4-benzpyrene which produced sarcomata in 2 out of 10 mice, these
were inactive.
Carcinogenic activity seems more general among the methyl derivatives of
3:4-benzpyrene. Including the active 8-methyl compound for which results are
recorded in Table III, data are now available for eight ofthe twelve theoretically
possible monomethylbenzpyrenes (Schiirch and Winterstein, 1935; Shear, 1939;
Shear and Leiter, 1940; Dunlap and Warren, 1941; Dunlap and Warren, quoted
by Fieser and Heymann, 1941; Dunlap, quoted by Jones, 1942). Of these only
two have proved inactive (the 2'- and 3'- methyl compounds). It is evident
from a survey of the data that, although 8-methyl- and 8-methoxy-3:4-benz-
pyrene are both strongly carcinogenic, no general parallelism exists in the car-
cinogenic response of other methyl and methoxy derivatives of benzpyrene.
For instance, both 4'-methyl- and 5-methyl-3:4-benzpyrene gave tumours in a
very high proportion of the treated mice although, as stated above, the 4'-methoxy
compound was inactive and the 5-methoxy compound feebly active.
A similar lack of parallelism is shown by methyl- and methoxy-derivatives
of other polycyclic aromatic hydrocarbons (compare 9:10-dimethyl- and 9:10-
dimethoxy-1:2-benzanthracene; although the former is a verypotent carcinogen,
the latter failed to produce tumours in 15 months after subcutaneous injection
of 2 mg. into each of 10 mice (Berenblum and Schoental, 1944)).
The fact that 8-methyl-3:4-benzpyrene is an effective carcinogen discounts
the suggestion of Greenwood (1951), who explained the inactivity of 4'-methyl-
1:2-benzanthracene by postulating that a methyl substituent at the metabolically
attacked position may interfere with the metabolic process and thus destroy the
potential activity of the compound.
SUMMARY.
Pure synthetic 8-hydroxy, 8-methoxy- and 8-methyl-3:4-benzpyrene have
been tested for carcinogenic activity with the following results:
(a) 8-Hydroxy-3:4-benzpyrene (a phenolic metabolite of 3:4-benzpyrene)
produced tumours after more than 69 weeks of application to the skin of mice,
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but none by the subcutaneous route. Thus its carcinogenic activity is rather
feeble.
(b) 8-Methoxy-3:4-benzpyrene produced sarcomata readily in mice and rats
when injected subcutaneously. It also produced tumours not only in all the
mice but also in the skin of all the rats to which it was applied. The high malig-
nancy of the skin tumours in the rats was indicated by the presence of secondary
keratinizing carcinomata in the lymphoid tissues, and by the growth of transplants
in weanling rats. Thus, this methyl ether of a metabolite of 3:4-benzpyrene
ranks among the most potent carcinogens so far known for mice and rats.
(c) 8-Methyl-3:4-benzpyrene tested by the subcutaneous route in mice
produced in all the animals tested highly malignant haemorrhagic tumours
invading the adjacent muscle and other tissues. The potency of this methyl-
derivative is at least equal to that of 3:4-benzpyrene itself; tumours developed
very quickly, 50 per cent of the animals having tumours in 15 weeks.
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